ELEvanthia Lalla

Evanthia Lalla

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Evanthia Lalla has a total of 65 co-authors. Here are the top co-authors by number of shared publications:

  • Panos N. Papapanou

    Division of Periodontics, Section of Oral, Diagnostic and Rehabilitation Sciences, College of Dental Medicine Columbia University New York New York USA

    11 shared publications
  • Ira B. Lamster

    8 shared publications
  • Ann Marie Schmidt

    New York University School of Medicine, New York, New York

    6 shared publications
  • Georg Alexander Roth

    Department of Anesthesiology, General Intensive Care and Pain Medicine, Medical University of Vienna, Vienna, Austria; RAIC Laboratory 13C1, Medical University of Vienna, Vienna, Austria

    6 shared publications
  • B. Cheng

    Department of Biostatistics, Mailman School of Public Health, Columbia University, 630 W. 168th Street, PH7E-110, New York, NY 10032, USA

    3 shared publications
  • Bin Cheng

    Department of Biostatistics, Mailman School of Public Health, Columbia University, New York, NY

    3 shared publications

Latest Publications

  • Open Access

    Diabetes and oral disease: implications for health professionals

    by David A. Albert, Angela Ward, Pamela Allweiss, Dana T. Graves, William C. Knowler, Carol Kunzel, Rudolph L. Leibel, Karen F. Novak, Thomas W. Oates, Panos N. Papapanou, et al.

    “Diabetes and Oral Disease: Implications for Health Professionals” was a one‐day conference convened by the Columbia University College of Dental Medicine, the Columbia University College of Physicians and Surgeons, and the New York Academy of Sciences on May 4, 2011 in New York City. The program included an examination of the bidirectional relationship between oral disease and diabetes and the interprofessional working relationships for the care of people who have diabetes. The overall goal of the conference was to promote discussion among the healthcare professions who treat people with diabetes, encourage improved communication and collaboration among them, and, ultimately, improve patient management of the oral and overall effects of diabetes. Attracting over 150 members of the medical and dental professions from eight different countries, the conference included speakers from academia and government and was divided into four sessions. This report summarizes the scientific presentations of the event.a


  • Top Cited Papers

    Diabetes mellitus and periodontitis: a tale of two common interrelated diseases

    by Evanthia Lalla, Panos N. Papapanou

    Diabetes mellitus (a group of metabolic disorders characterized by hyperglycemia) and periodontitis (a microbially induced inflammatory disorder that affects the supporting structures of teeth) are both common, chronic conditions. Multiple studies have demonstrated that diabetes mellitus (type 1 and type 2) is an established risk factor for periodontitis. Findings from mechanistic studies indicate that diabetes mellitus leads to a hyperinflammatory response to the periodontal microbiota and also impairs resolution of inflammation and repair, which leads to accelerated periodontal destruction. The cell surface receptor for advanced glycation end products and its ligands are expressed in the periodontium of individuals with diabetes mellitus and seem to mediate these processes. The association between the two diseases is bidirectional, as periodontitis has been reported to adversely affect glycemic control in patients with diabetes mellitus and to contribute to the development of diabetic complications. In addition, meta-analyses conclude that periodontal therapy in individuals with diabetes mellitus can result in a modest improvement of glycemic control. The effect of periodontal infections on diabetes mellitus is potentially explained by the resulting increase in levels of systemic proinflammatory mediators, which exacerbates insulin resistance. As our understanding of the relationship between diabetes mellitus and periodontitis deepens, increased patient awareness of the link between diabetes mellitus and oral health and collaboration among medical and dental professionals for the management of affected individuals become increasingly important.


  • Identification of Unrecognized Diabetes and Pre-diabetes in a Dental Setting

    by E. Lalla, C. Kunzel, S. Burkett, B. Cheng, I.B. Lamster

    Many diabetic patients remain undiagnosed, and oral findings may offer an unrealized opportunity for the identification of affected individuals unaware of their condition. We recruited 601 individuals who presented for care at a dental clinic, were ≥ 40 years old, if non-Hispanic white, and ≥ 30 years old, if Hispanic or non-white, and had never been told they have pre-diabetes or diabetes. Those with at least one self-reported diabetes risk factor (N = 535) received a periodontal examination and a point-of-care hemoglobin A1c (HbA1c) test. A fasting plasma glucose (FPG) test was used as the study outcome, signifying potential diabetes or pre-diabetes. Performance characteristics of simple models of dysglycemia (FPG ≥ 100 mg/dL) identification were evaluated and optimal cut-offs identified. A model including only two dental variables had an estimated area under the receiver operating characteristic curve (AUC) of 0.65. The addition of a point-of-care HbA1c test improved the AUC to 0.79 (p < 0.001). The presence of ≥ 26% deep pockets or ≥ 4 missing teeth correctly identified 73% of true cases; the addition of an HbA1c ≥ 5.7% increased correct identification to 92%. Analysis of our data suggests that oral healthcare professionals have the opportunity to identify unrecognized diabetes and pre-diabetes in dental patients and refer them to a physician for further evaluation and care.


  • Receptor for advanced glycation endproducts mediates pro-atherogenic responses to periodontal infection in vascular endothelial cells

    by Andreas Pollreisz, Barry I. Hudson, Jong S. Chang, Wu Qu, Bin Cheng, Panos N. Papapanou, Ann Marie Schmidt, Evanthia Lalla


  • Enhanced monocyte migration and pro-inflammatory cytokine production byPorphyromonas gingivalisinfection

    by A. Pollreisz, Y. Huang, G. A. Roth, B. Cheng, M. Kebschull, P. N. Papapanou, A. M. Schmidt, E. Lalla

    Porphyromonas gingivalis, a major periodontal pathogen, has been reported to be involved in atherogenesis. In order to further understand this pathogen's link with systemic inflammation and vascular disease, we investigated its influence on murine monocytes and macrophages from three different sources. Concanavalin A-elicited peritoneal macrophages, peripheral blood monocyte-derived macrophages and WEHI 274.1 monocytes were infected with either P. gingivalis 381 or its non-invasive fimbriae-deficient mutant, DPG3. Infection with P. gingivalis 381 markedly induced monocyte migration and significantly enhanced production of the pro-inflammatory cytokines, tumor necrosis factor-alpha and interleukin-6. Consistent with a role for this pathogen's major fimbriae and/or its invasive capacity, infection with DPG3 had a minimal effect on both monocyte attraction and pro-inflammatory cytokine production. Since monocyte recruitment and activation are important steps in the development of vascular inflammation and atherosclerosis, these results suggest that P. gingivalis infection may be involved in these processes.


  • Porphyromonas gingivalis infection and prothrombotic effects in human aortic smooth muscle cells

    by Georg A. Roth, Klaus Aumayr, Mary Beth Giacona, Panos N. Papapanou, Ann Marie Schmidt, Evanthia Lalla


  • Open Access

    Oral Disease Burden in Northern Manhattan Patients With Diabetes Mellitus

    by Evanthia Lalla, David B. Park, Panos N. Papapanou, Ira B. Lamster

    Objectives. We explored the association between diabetes mellitus and oral disease in a low-socioeconomic-status urban population. Methods. Dental records of 150 adults with diabetes and 150 nondiabetic controls from the dental clinic at Columbia University in Northern Manhattan matched by age and gender were studied. Results. There was a 50% increase in alveolar bone loss in diabetic patients compared with nondiabetic controls. Diabetes, increasing age, male gender, and use of tobacco products had a statistically significant effect on bone loss. Conclusions. Our findings provide evidence that diabetes is an added risk for oral disease in this low-income, underserved population of Northern Manhattan. Oral disease prevention and treatment programs may need to be part of the standards of continuing care for patients with diabetes


  • Open Access

    Porphyromonas gingivalisinfection and cell death in human aortic endothelial cells

    by Georg A. Roth, Hendrik J. Ankersmit, Vinette B. Brown, Panos N. Papapanou, Ann Marie Schmidt, Evanthia Lalla

    Porphyromonas gingivalis is a periodontal pathogen that promotes a proatherogenic response in endothelial cells. Cell death responses of human aortic


  • Effects of periodontal therapy on serum C‐reactive protein, sE‐selectin, and tumor necrosis factor‐α secretion by peripheral blood‐derived macrophages in diabetes. A pilot study

    by E. Lalla, S. Kaplan, J. Yang, G. A. Roth, P. N. Papapanou, S. Greenberg

    Background and Objective:  Diabetes is associated with an increased risk for vascular disease and periodontitis. The aim of this study was to assess the effects of periodontal treatment in diabetes with respect to alterations in the pro‐inflammatory potential of peripheral blood mononuclear cells.Material and Methods:  Ten patients with diabetes and moderate to severe periodontitis received full‐mouth subgingival debridement. Blood samples for serum/plasma and mononuclear cell isolation were collected prior to and 4 wk after therapy. Mononuclear cells were analyzed by flow cytometry and stimulated with lipopolysaccharide or ionomycin/phorbol ester to determine the pro‐inflammatory capacity of macrophages and lymphocytes, respectively.Results:  Following periodontal treatment, all patients demonstrated a significant improvement in clinical periodontal status (p < 0.05), despite only modest reduction in subgingival bacterial load or homologous serum immunoglobulin G titers. CD14+ blood monocytes decreased by 47% (p < 0.05), and the percentage of macrophages spontaneously releasing tumor necrosis factor‐α decreased by 78% (p < 0.05). There were no significant changes in the capacity of lymphocytes to secrete interferon‐γ. Among a number of serum inflammatory markers tested, high‐sensitivity‐C‐reactive protein significantly decreased by 37% (p < 0.01) and soluble E‐selectin decreased by 16.6% (p < 0.05).Conclusion:  These data suggest a reduced tendency for monocyte/macrophage‐driven inflammation with periodontal therapy and a potential impact on atherosclerosis‐related complications in diabetic individuals.